Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HPV DNA vaccines.

Michelle Moniz1, Morris Ling, Chien-Fu Hung

  • 1Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|November 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathological characterization of cervical squamous cell carcinoma with <i>PIK3CA</i> hotspot mutation: A single-institution study.

Oncology letters·2026
Same author

Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancer.

The Journal of clinical investigation·2026
Same author

A mouse model of HPV-associated cervicovaginal carcinosarcoma with comparative analysis to human clinical cases.

Cell & bioscience·2026
Same author

Personalizing DNA Cancer Vaccines.

Journal of personalized medicine·2025
Same author

Comparative Analysis Reveals Recurrent Molecular Alterations in Low-Risk Human Papillomavirus 6 and Human Papillomavirus 11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019.

Annals of hepatology·2025
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Sialomucin complex in tumors and tissues.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The DCC protein -- neural development and the malignant process.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles

Therapeutic vaccines targeting human papillomavirus (HPV) E6 and E7 proteins show promise for treating cervical cancer. DNA vaccines encoding HPV antigens offer a potential strategy for preventing and controlling HPV-associated malignancies.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Human papillomaviruses (HPV), especially HPV type 16, are the main cause of cervical cancer.
  • Targeting HPV-specific immune responses could prevent or treat HPV-associated cervical malignancies.
  • HPV oncogenic proteins E6 and E7 are crucial for cellular transformation and are ideal targets for therapeutic vaccines.

Purpose of the Study:

  • To explore the potential of vaccines targeting HPV proteins for preventing and treating cervical cancer.
  • To investigate DNA vaccines as a strategy for inducing HPV-specific immune responses.
  • To assess the role of HPV capsid and oncogenic proteins in vaccine development.

Main Methods:

  • Genetic immunization using naked DNA encoding HPV antigens (L1, L2, E6, E7).

Related Experiment Videos

  • Stimulation of antigen-specific humoral and cellular immune responses through DNA vaccination.
  • Investigation of strategies to enhance the efficacy of DNA vaccines for HPV-related conditions.

    • Main Results:

    • HPV capsid proteins (L1, L2) can induce neutralizing antibodies against HPV particles.
    • HPV oncogenic proteins (E6, E7) are expressed in HPV-associated carcinomas, making them targets for therapeutic vaccines.
    • DNA vaccines encoding HPV antigens stimulate antigen-specific immune responses.

    Conclusions:

    • Vaccines targeting HPV E6 and E7 proteins offer a potential therapeutic strategy for HPV-associated neoplasia.
    • DNA vaccines hold promise for the prevention and treatment of HPV infections and related cervical lesions.
    • Further research is needed to optimize DNA vaccine strategies for controlling HPV-associated malignancies.